GLP-1 is released from intestinal L-cells in a biphasic pattern following meal ingestion: an initial early peak within 1015 minutes, driven primarily by neural and endocrine signals from the upper gastrointestinal tract, is followed by a sustained second peak at 3060 minutes driven by direct nutrient contact with L-cells in the distal ileum and colon
Despite these variations, each version supports the same health and wellness benefits
This medication has been developed for the treatment of type 2 diabetes due to its comprehensive effects in regulating appetite, reducing food intake, and improving glycemic control
Semaglutide, a tried-and-true GLP-1 receptor agonist, has already earned its stripes in the battle against weight gain and diabetes
Key Takeaways: Patients notice effects of GLP-1 medications like a reduced appetite within 12 weeks, though this can vary
Manufacturer Assistance Programs Aside from copay cards, companies also run assistance gigs for folks strapped for cash or lacking insurance
